Top Markets
#1 Akedo Akedo +59.62%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.64%
#4 Cross Cross +40.87%
#5 OVERTAKE OVERTAKE +34.07%
#6 Black Phoenix Black Phoenix +33.88%
#7 Velvet Velvet +33.26%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.83%
#9 Cap Cap +15.68%
#10 Bitway Bitway +11.60%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Valion Bio, Inc. Valion Bio, Inc.

Valion Bio, Inc.

VBIO
Rank in Stocks #38930
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead... Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Share Price
$0.1818
Market Cap
$752.91K
Change (1 day)
6.44%
Change (1 year)
-94.81%
Country
US
Trade Valion Bio, Inc. (VBIO)

Category

Healthcare
Stock price history for Valion Bio, Inc. (VBIO)
Highest end of day price: $0.25 on 2026-08-01

Lowest end of day price: $7.60K on 2021-11-01
Stock price history of Valion Bio, Inc. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -21.25%
2025 -56.71%
2024 -86.09%
2023 -97.85%
2022 -79.33%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $506.56 29.79%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $841.86 29.03%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.43 7.09%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $252.30 11.46%
BE